INTRODUCTION
The ovalbumin (Ov) gene has served as a unique model system in which to study tissue-specific gene expression and steroid hormone gene regulation for over 25 years. After initial stimulation by estrogen, this gene is responsive to four classes of steroid hormones: estrogen, androgen, glucocorticoid, and progesterone. Historically, we have used pBLCAT to analyze the cis-acting elements in the 5´ flanking region of this gene and the effects of overexpressing trans-acting factors. In an effort to increase the sensitivity of our analyses, limit the use of radioactive material, and decrease the time required to obtain experimental results, the pGL3 Dual-Luciferase ® Reporter Assay System was evaluated for use in our system.
While the pGL3 vectors are designed to be transcriptionally neutral, proper controls are necessary to ensure that experimental treatments and/or overexpression of transcriptional regulators do not affect the promotorless vectors or the vectors containing promoters that will be used as internal controls (1) . Numerous reports document the transcription factors and experimental treatments that transactivate or repress promoterless reporter vectors and internal control vectors containing promoters such as cytomegalovirus (CMV), herpes simplex virus thymidine kinase (HSV-TK), and simian virus 40 (SV40) (2) (3) (4) (5) (6) (7) 
MATERIALS AND METHODS

Oviduct Tubular Gland Cell Culture and Transfection
White leghorn chicks were treated with estrogen in the form of diethystilbesterol (DES; Hormone Pellet Press, Leawood, KS, USA). DES pellets (20 mg) were implanted subcutaneously in the neck for 2 weeks, and the pellets were subsequently withdrawn 2 days prior to isolation of tubular gland cells as previously described in detail (8) Oviduct cells were transfected with pGL3 luciferase reporter plasmids and cultured alone or in the presence of 100 nM E 2 , 1 µM C, or E 2 and C. Cells were transfected with 1 µg promoterless vector (pGL3-basic and pRL null) or 5 ng vector (pRL-CMV) containing a promoter. Luciferase activity was measured 24 h after transfection and is reported as the average fold change relative to basal activity for each vector. The relative light units (RLUs) from three separate experiments with duplicate dishes per treatment were averaged and analyzed by analysis of variance (ANOVA). The sem is indicated by the error bars, and the P value for each is <0.0001.
SHORT TECHNICAL REPORTS
were assayed for luciferase activity using the Dual Luciferase Reporter Assay kit (Promega). Relative light units (RLU) were determined using 100 µL of the appropriate substrate and a Lumat LB 9507 luminometer (EG&G-Berthold, Bad Wildbad, Germany). The concentrations of the cell extracts were determined using the Bradford method, and the raw RLUs were normalized to protein concentration. The luciferase values represent the light emitted over a period of 10 s and are expressed as fold change with steroid treatment for each vector.
MCF-7 Cell Culture and Transfection
MCF-7 cells (ATCC, Manassas, VA, USA) were maintained in minimum essential medium (MEM; Gibco), 10% fetal bovine serum (FBS; Tissue Culture Biological, Tulare, CA, USA), 10 µg/ mL bovine insulin (Sigma), and 50 U and 50 µg/mL PenStrep (Invitrogen). Twenty-four hours prior to transfection, the cells were cultured in MEM (minus phenol red), 10% charcoal-stripped FBS, insulin, and PenStrep. Cells were transfected with a total of 400 ng DNA using Effectene transfection reagent according to the manufacturer's directions. DNA concentrations were held constant by the addition of appropriate amounts of pBlue-TOPO. Cells were cultured for 24 h in MEM (minus phenol red), 10% charcoal stripped FBS, insulin, and PenStrep either alone or with 1 nM 17β-estradiol, 10 nM hydrocortisone (HCT; Sigma), or 17β-estradiol and HCT as indicated. Following transfection, the cells were harvested and lysed, and the protein extracts were assayed for luciferase activity as described above.
Plasmids
The pGL3 luciferase vectors were obtained from Promega, and the pBlue-TOPO vector was obtained from Invitrogen. The pGL3 vectors consist of pGL3 basic (firefly), pRL null (Renilla), and pRL-CMV. The pGL4 vectors, provided as a generous gift by Promega, include pGL4. 
Sequence Analysis
The sequences of pGL3-basic, pGL4.10 [luc 2], pRL null, and pGL4.70 [hRluc] were analyzed for the presence of transcription factor binding sites using the TRANSFAC program at bimas.dcrt.nih.gov/molbio/signal. The sequences were then analyzed for changes in transcription factor binding sites..
RESULTS AND DISCUSSION
The pGL3 luciferase reporter vectors are routinely used for the analysis of steroid hormone responsive genes. While the pRL-TK (Renilla luciferase gene controlled by the TK promoter) has been observed to be responsive to dihydrotestosterone and dexamethasone (9) , the effects of estrogen and natural glucocorticoids remain unreported. For the present study, we transfected primary chicken oviduct tubular gland cells with pGL3 basic, pRL null, and pRL-CMV and evaluated the effects of 17β-estradiol, corticosterone, or the combination of 17β-estradiol and corticosterone on these vectors (Figure 1) . While 100 nM17β-estradiol had little or no effect on these vectors, the addition of 1 µM corticosterone transactivated pGL3-basic firefly 2-fold, and the combination of 17β-estradiol and corticosterone activated this promoterless vector 3-fold. The promoterless pRL null Renilla vector was unaffected by steroid hormone treatment, however, the addition of the CMV promoter (pRL-CMV) to this vector resulted in a 7-to 8-fold induction of Renilla activity in the presence of corticosterone, while no additional increase was observed with the additon of 17β-estradiol. This result indicates that the CMV promoter is responsive to glucocorticoid treatment, and therefore, pRL-CMV is not an appropriate vector for use as an internal control in studies involving the use of glucocorticoids. Furthermore, G l u c o c o r t i c o i d s r eg u l a t e transcription by activating the glucocorticoid receptor, which binds glucocorticoid response elements in promoters of target genes. Glucocorticoid receptors also associate with transcription factors such as COUP-TFII, AP1, NF-1, NF-кB, and SP1, among others, to antagonize or stimulate the activation potential of these transcription factors (10) . The glucocorticoid receptor can interact with NF-1 and SP1 to enhance activation potential, and mutation of an NF-1 binding site in the MMTV long terminal repeat (LTR) abolishes the ability of glucocorticoids to activate this promoter (11) . Our results show that pGL3-basic and pRL-CMV are glucocorticoid-responsive in primary oviduct tubular gland cell culture. These results confirm that the pGL3 basic vector and CMV promoter both contain sequences that are transactivated by glucocorticoid treatment. Therefore, newly engineered pGL4 vectors were evaluated for estrogenand glucocorticoid-responsiveness.
In an effort to identify luciferase reporter vectors that are suitable for our system, pGL4 vectors were obtained from Promega and evaluated for steroid hormone responsiveness in primary oviduct tubular gland cells and MCF-7 cells. Control vectors used to determine estrogen or glucocorticoid responsiveness were pGL3-TK101 and pGL3-MMTV, respectively. Glucocorticoid-responsive primary oviduct tubular gland cells were transfected with the pGL4 vectors and treated with 100 nM 17β-estradiol, 1 μM corticosterone, or 17β-estradiol and corticosterone (Figure 2) . The promoterless pGL4.10 [luc 2] firefly vector was transactivated 11-to 12-fold with corticosterone or with estradiol and corticosterone. This is a 4-fold greater induction than that observed with pGL3-basic. Analysis of the vector sequence revealed numerous NF-1 sites and additional SP1 sites in pGL4.10 [luc 2], which may explain the increase in activation of this promoterless vector in the presence of glucocorticoid ( Table  1) (Table 1 ) may permit these vectors to be used in overexpression studies and under experimental conditions for which the pGL3 vectors are not suited. Columns 2 and 3 reflect the number of sites deleted in pGL4 compared with the total number of sites in pGL3 vectors or the number of sites added to pGL4 vectors. None of these sites have been tested for activity. TF, transcription factor.
As expected, MCF-7 cells are responsive to estrogen but not to glucocorticoid as shown by the 6-fold increase in luciferase activity of the pGL3-TK101 vector in the presence of 17β-estradiol and no induction of pGL3-MMTV luciferase activity in the presence of HCT (Figure 3 ). These cells were transfected with the pGL4 vectors and treated with 1 nM 17β-estradiol,10 nM HCT, or both. The promoterless pGL4. 10 The sequences of pGL3-basic, pGL4.10 [luc 2], pRL null, and pGL4.70 [hRluc] were analyzed for transcription factor binding sites using the TRANSFAC database. The transcription factor binding site profiles for the pGL4 vectors were compared with their respective pGL3 counterparts, and significant changes in transcription factor binding sites are described in Table 1 . Of particular note, is the complete elimination or significant reduction of GATA sites in both pGL4 vectors. Additionally, background transcription may be further minimized by the reduction of TATA, TBP, and TFIID binding sites. Unfortunately, as a result of these changes, there is an increase in the number of binding sites for SP1. While these putative SP1 sites have not been tested, our results suggest that some of these sites are functional. A possible solution may be the use of vectors containing both the firefly and Renilla genes. Two such vectors have been described (12, 13) , each of which carries both luciferase genes, but the pFRL2 vector (11) orients the genes in opposite directions to minimize leaky transcription of the Renilla gene. Experiments are in progress to evaluate both of these vectors.
In conclusion, our results underscore the necessity of appropriate controls when using expression vectors as reporters or internal controls in transient transfection assays. A reporter vector that is influenced by treatment or overexpression of transcription factors could cause experimental results to be inflated or underreported, depending upon the transcriptional effect. Likewise, it is not safe to assume that a vector reported to be transcriptionally neutral in one cell type will behave similarly in every other cell type when subjected to like treatment. In addition to proper controls, sequence analysis of reporter vectors for transcription factor binding sites may be advisable to discern which vector and/or promoter is best suited to experimental conditions. Luciferase activity was measured 24 h after transfection and is reported as the average fold change relative to basal activity for each vector. This is one experiment done in duplicate per treatment that has been repeated with similar results at least twice.
